The stocks that represent the most compelling investment opportunities are the ones most poised to outperform the rest. But how are investors supposed to know which stocks have the strongest prospects for long-term growth? That’s where the TipRanks Top Analyst Stocks tool comes in. It finds all the stocks that have garnered buy ratings from the Street’s most trusted analysts. Importantly, you can organize the search results by upside potential.
Stocks trading under $15 aren’t necessarily cheap. Yet, they are still quite popular among investors as they present the chance to take a larger position in a company. We used the tool to find 3 of the top-rated tech stocks under $15. Each boasts impressive upside potential and has amassed support from the best-performing analysts.
Let’s take a closer look:
RumbleON Inc. (RMBL)
The first stock on our list offers an online platform for buying and selling vehicles. The platform utilizes a capital-light network of 17 regional partnerships and is designed for dealers as well as individual customers. While RMBL is down 24% year-to-date, analysts are saying it’s undervalued at $4.08.
On August 12, the company reported that its second quarter revenue reached a record high of $270 million, up from $14 million in the prior-year quarter. Not to mention its powersport sales saw 98% year-over-year growth.
RMBL has made significant efforts to expand its product offering. The company added cars and trucks to RumbleOn.com and added cash offers for this segment in May 2019.
It has also shifted focus towards growing RumbleOnClassifieds.com, with it now representing the third largest U.S. consumer listing site for powersports and surpassing eBay’s size in the space. Management stated that it has additional plans to add auto listings to the platform by the end of the year.
5-star B.Riley analyst Lee Krowl noted that RMBL’s shift away from less profitable inventory is an important step in the right direction. “Management indicated that they expect flat Q/Q revenue growth in 3Q with a focus on enhancing the profitability of the company driven by optimizing away from less profitable inventory,” he added.
The analyst reiterated a Buy rating on RMBL stock with a $9 price target, implying 72% upside potential from current levels. (To watch Krowl’s track record, click here)
5-star JMP analyst Ronald Josey cited RMBL’s expansion efforts as especially promising. On July 30, he initiated coverage on the stock with a Buy rating while setting a $10 price target, which implies nearly 150% upside. (To watch Josey’s track record, click here)
“Ultimately, we believe the RumbleOn platform can expand to most types of vehicles — cars, bikes, RVs, boats, ATVs — which collectively represent ~$1 trillion in annual sales across what we view as a highly fragmented industry. While it remains early days at RumbleOn, by keeping its overall days sales outstanding (DSOs) to under 30, growing consumer awareness and as its sales mix evolves to about 50/50% dealer/consumer over the next several years from its current 90/10%, we think profitability should ramp materially,” Josey explained.
The rest of the Street is cautiously optimistic about RMBL. It has a ‘Moderate Buy’ analyst consensus and a $9 average price target, suggesting 108% upside. (See RMBL’s price targets and analyst ratings on TipRanks)
Change Healthcare Inc. (CHNG)
Change Healthcare uses big data to offer revenue and payment cycle management as well as solutions for clinical information exchange, connecting payers, providers and U.S. healthcare system patients. Its products provide a more efficient and cost-effective way to transfer healthcare information. With the share price currently at $13.16, this stock looks like a steal.
The healthcare-technology company, which went public in June, is already showing promising results even with the implementation of the new revenue recognition regulation, ASC 606. Following its recent Q1 earnings release, shares soared nearly 9% yesterday. It posted $856 million in sales, coming in ahead of the $796 million consensus estimate.
The company also announced during the earnings release that it had been awarded a six year contract to continue providing its clinical interoperability services to CommonWell Health Alliance and introduced InterQual 2019. InterQual 2019 is its clinical decision support solution which includes a ‘Hospital in the Home’ program. These programs are used as alternatives to some acute inpatient stays.
With healthcare spending expected to reach $6 trillion by 2027, analysts believe CHNG looks poised to meet the demands of this ever expanding market.
Five-star Piper Jaffray analyst Sean Wieland gave the stock a small boost after the company’s strong fiscal Q1 earnings release. The analyst reiterated a Buy rating and raised his price target from $18.50 to $19, suggesting 44% upside potential. “Change’s revenue and profitability came in marginally ahead of estimates after factoring out the impact of adopting ASC 606,” he explained. (To watch Wieland’s track record, click here)
Barclays analyst Manav Patnaik thinks CHNG has demonstrated growth prospects that go above and beyond. “We believe the company has a solid foundation to leverage its data and analytics in the growing healthcare industry,” the five-star analyst noted. The analyst rates the stock a Buy along with an $18 price target, implying 37% upside.
CHNG has a ‘Strong Buy’ analyst consensus and a $19 price target, indicating 42% upside potential. (See CHNG’s price targets and analyst ratings on TipRanks)
Fastly Inc. (FSLY)
Fastly created an innovative edge cloud computing platform that includes a content delivery network, internet security services, load balancing and video and streaming services. At $14.85, some analysts argue this tech stock is undervalued.
On August 8, the company reported a second quarter revenue gain of 34% year-over-year. However, its earnings loss was wider than analysts originally expected. Despite mixed earnings results, management stated that its new product offerings could drive a turnaround.
FSLY launched 60 code-based solutions that will make it safer and faster for developers to discover, test, customize and deploy edge cloud solutions.
SVP of Customer Solutions, Adam Denenberg added, “Our programmable edge has always been one of the capabilities that our customers love about our platform, so we made a commitment to make it easier for developers to use all the innovative solutions our customer base is building on our edge. Providing an easy way to use prebuilt solutions on our platform was just a logical evolution to allow our customers to innovate even faster, and this launch marks another phase in our drive to empower developers around the world.”
Four-star Piper Jaffray analyst James Fish believes that FSLY’s low price represents a unique buying opportunity for investors. “We believe Fastly will benefit from strong, sustainable underlying market dynamics as well as the evolutionary shift towards edge workloads,” he said. On August 14, he initiated coverage with a Buy and set a $21 price target. The Piper Jaffray analyst thinks share prices could jump 41% over the next twelve months.
Stifel Nicolaus analyst Brad Reback tells investors to block out the gross margin noise. “We are still believers in Fastly’s ability to drive strong net new customer additions, long-term market opportunity and relatively attractive valuation,” he explained on August 9. Reback reiterated his Buy rating and $25 price target, implying 68% upside. The five-star analyst has a 65% success rate and gets an average return of 15% per rating.
The Street also takes a bullish stance on Fastly. It has a ‘Strong Buy’ analyst consensus and a $25 average price target, suggesting 65% upside potential. (See FSTL’s price targets and analyst ratings on TipRanks)